Skip to main content
Premium Trial:

Request an Annual Quote

Geospiza Acquires GeneSifter Microarray Software from VizX

NEW YORK (GenomeWeb News) – Geospiza has signed a definitive agreement to acquire the GeneSifter Data Analysis product from VizX Labs, the Seattle-based firm said today.
 
Geospiza said GeneSifter is a gene expression analysis platform for both microarrays and next-generation sequencing. It expects the integration of GeneSifter with its own FinchLab will be “fast and seamless.”
 
“GeneSifter will expand our market by addressing the demand for sophisticated data analysis across microarray, capillary electrophoresis, and next-generation sequencing platforms," Geospiza President Rob Arnold said in a statement.
 
Financial terms of the acquisition were not disclosed.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more